The Sentinel

The Sentinel Breakthroughs in Health & Technology | Trends in Finance | March 12, 2017

IN THIS ISSUE:

FEATURE: The Case for a Healthcare Futures Market
Dennis Purcell and his team at Poliwogg outline the prospects and potential to bring stability to the healthcare market through creating a futures exchange, starting with a diabetes index.

COMPANY NEWS:
Life Care Medical Devices adds prominent industry expert and investor to board
Neurotrope advances Phase 2 Alzheimer’s trial
Lattice Biologics reports Q1 highlights and progress on new osteoarthritis treatment

INTERVIEWS:
Kevin Connolly, CEO of Vesiflo on the $1 billion catheter market
Richard Daly, CEO of Neuralstem on major depressive disorder
Christopher Schaber PhD, CEO of Soligenix on orphan drugs and biodefense

IDEAS & TECHNOLOGIES:
Relmada Therapeutics’ pain management products
ITUS’ blood test detects early forms of solid tumor-based cancers
On-Site Waste Tech’s oven-sized incinerators destroy medical waste
Premier Biomedical’s cannabinoid opioid-free pain management solutions

INDUSTRY NEWS:
China BioVentures to sponsor SEBP 2017 conference in Shanghai
Galien Foundation launches search for Prix Galien nominees

Categories: The Sentinel